These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 8710022

  • 21. Li-Fraumeni syndrome and the role of the p53 tumor suppressor gene in cancer susceptibility.
    Akashi M, Koeffler HP.
    Clin Obstet Gynecol; 1998 Mar; 41(1):172-99. PubMed ID: 9504235
    [Abstract] [Full Text] [Related]

  • 22. [Li-Fraumeni syndrome and the p53 gene].
    Thoresen SO.
    Tidsskr Nor Laegeforen; 1992 Mar 10; 112(7):887-9. PubMed ID: 1557756
    [Abstract] [Full Text] [Related]

  • 23. [p53 transgenic and knockout mice].
    Oda H.
    Nihon Rinsho; 2000 Jun 10; 58(6):1250-4. PubMed ID: 10879049
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.
    Frebourg T, Kassel J, Lam KT, Gryka MA, Barbier N, Andersen TI, Børresen AL, Friend SH.
    Proc Natl Acad Sci U S A; 1992 Jul 15; 89(14):6413-7. PubMed ID: 1631137
    [Abstract] [Full Text] [Related]

  • 26. [Tumor suppressor gen mutation in the germ line: its significance in familial and sporadic tumors].
    Müller H, Scott RJ.
    Schweiz Med Wochenschr; 1995 Jul 29; 125(30):1445-54. PubMed ID: 7676234
    [Abstract] [Full Text] [Related]

  • 27. Balanced t(11;15)(q23;q15) in a TP53+/+ breast cancer patient from a Li-Fraumeni syndrome family.
    Sherif ZA, Danielsen M.
    Cancer Genet Cytogenet; 2006 Jul 01; 168(1):50-8. PubMed ID: 16772121
    [Abstract] [Full Text] [Related]

  • 28. High frequency of de novo mutations in Li-Fraumeni syndrome.
    Gonzalez KD, Buzin CH, Noltner KA, Gu D, Li W, Malkin D, Sommer SS.
    J Med Genet; 2009 Oct 01; 46(10):689-93. PubMed ID: 19556618
    [Abstract] [Full Text] [Related]

  • 29. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families.
    Varley JM, McGown G, Thorncroft M, Santibanez-Koref MF, Kelsey AM, Tricker KJ, Evans DG, Birch JM.
    Cancer Res; 1997 Aug 01; 57(15):3245-52. PubMed ID: 9242456
    [Abstract] [Full Text] [Related]

  • 30. p53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome.
    Quesnel S, Verselis S, Portwine C, Garber J, White M, Feunteun J, Malkin D, Li FP.
    Oncogene; 1999 Jul 08; 18(27):3970-8. PubMed ID: 10435620
    [Abstract] [Full Text] [Related]

  • 31. The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations.
    Finkova A, Vazna A, Hrachovina O, Bendova S, Prochazkova K, Sedlacek Z.
    Cancer Genet Cytogenet; 2009 Aug 08; 193(1):63-6. PubMed ID: 19602465
    [Abstract] [Full Text] [Related]

  • 32. Identification of novel TP53 mutations in familial and sporadic cancer cases of German and Swiss origin.
    Bendig I, Mohr N, Kramer F, Weber BH.
    Cancer Genet Cytogenet; 2004 Oct 01; 154(1):22-6. PubMed ID: 15381368
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Identification and characterization of a novel germ line p53 mutation in familial gastric cancer in the Japanese population.
    Yamada H, Shinmura K, Okudela K, Goto M, Suzuki M, Kuriki K, Tsuneyoshi T, Sugimura H.
    Carcinogenesis; 2007 Sep 01; 28(9):2013-8. PubMed ID: 17690113
    [Abstract] [Full Text] [Related]

  • 35. [Cancer family syndrome in lung cancer--Li-Fraumeni syndrome in lung cancer].
    Tomita M, Tagawa Y, Tsuji T, Tsuji H, Ayabe H.
    Nihon Rinsho; 1995 Nov 01; 53(11):2716-21. PubMed ID: 8538032
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers.
    Nichols KE, Malkin D, Garber JE, Fraumeni JF, Li FP.
    Cancer Epidemiol Biomarkers Prev; 2001 Feb 01; 10(2):83-7. PubMed ID: 11219776
    [Abstract] [Full Text] [Related]

  • 38. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome.
    Olive KP, Tuveson DA, Ruhe ZC, Yin B, Willis NA, Bronson RT, Crowley D, Jacks T.
    Cell; 2004 Dec 17; 119(6):847-60. PubMed ID: 15607980
    [Abstract] [Full Text] [Related]

  • 39. Risk stratification in cancer predisposition syndromes: lessons learned from novel molecular developments in Li-Fraumeni syndrome.
    Tabori U, Malkin D.
    Cancer Res; 2008 Apr 01; 68(7):2053-7. PubMed ID: 18381406
    [Abstract] [Full Text] [Related]

  • 40. Turcot's syndrome of glioma and polyposis occurs in the absence of germ line mutations of exons 5 to 9 of the p53 gene.
    Kikuchi T, Rempel SA, Rutz HP, de Tribolet N, Mulligan L, Cavenee WK, Jothy S, Leduy L, Van Meir EG.
    Cancer Res; 1993 Mar 01; 53(5):957-61. PubMed ID: 8439970
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.